Emerging nanoparticle-based therapies for pancreatic cancer: Current clinical landscape
{{output}}
Pancreatic cancer, particularly ductal adenocarcinoma (PDAC) is one of the most aggressive and lethal subtypes due to late diagnosis, the absence of early biomarkers, and the presence of a complex tumor microenvironment (TME). This TME is characterized by a de... ...